Xtant Medical to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
Xtant Medical Holdings (NYSE American: XTNT), a global medical technology company specializing in spinal disorder treatments, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Xtant Medical Holdings (NYSE American: XTNT), a global medical technology company specializing in spinal disorder treatments, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase. The event will take place from August 13-15, 2024 at the InterContinental Boston.
Sean Browne, President and CEO, and Scott Neils, CFO, will represent Xtant Medical at the conference. Browne is scheduled to present on Wednesday, August 14th at 11:00 a.m. Eastern. Investors and interested parties can access a video webcast of the presentation through the provided link.
This conference participation offers Xtant Medical an opportunity to showcase its surgical solutions and connect with potential investors and industry professionals.
Details
News Market Reaction – XTNT
The recorded move for XTNT in the trading session of this news was +0.40%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BELGRADE, MT / ACCESSWIRE / July 25, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will attend the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase being held August 13-15, 2024 at the InterContinental Boston, an IHG Hotel.
Sean Browne, President and Chief Executive Officer will present on Wednesday, August 14th at 11:00 a.m. Eastern.
A video webcast of the presentation will be available at: https://wsw.com/webcast/canaccord98/xtnt/2523378
About Xtant Medical Holdings, Inc.
Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (https://xtantmedical.com/) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.
Investor Relations Contact
Brett Maas • Managing Partner, Hayden IR
brett@haydenir.com • (646) 536-7331
SOURCE: Xtant Medical Holdings
View the original press release on accesswire.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.